Table 3

HRs for the RR of cardiovascular disease (CVD) mortality and all-cause mortality in people with type 2 diabetes (T2D) compared with all non-diabetics according to prevalent coronary heart disease (chd) and statin use* in the AGES-Reykjavik Study, 2002–2006

Adjusted for age and sexAdjusted for age, sex, and CVD risk factorsAdjusted for age, sex, CVD risk factors and C-reactive protein
HR (95% CI)HR (95% CI)HR (95% CI)
Death from CVD
 All T2D1.71 (1.35 to 2.17)1.48 (1.15 to 1.90)1.45 (1.13 to 1.86)
 According to CHD and statin use
  T2D with CHD not on statins4.71 (2.93 to 7.58)3.33 (2.02 to 5.50)3.20 (1.94 to 5.29)
  T2D with CHD on statins1.92 (1.08 to 3.43)1.51 (0.83 to 2.75)1.55 (0.85 to 2.82)
  T2D without CHD and not on statins1.53 (1.14 to 2.05)1.40 (1.03 to 1.89)1.34 (0.99 to 1.82)
  T2D without CHD and on statins0.83 (0.37 to 1.85)0.71 (0.31 to 1.62)0.75 (0.33 to 1.69)
Death from all causes
 All T2D1.44 (1.22 to 1.69)1.35 (1.14 to 1.61)1.32 (1.11 to 1.57)
 According to CHD and statin use
  T2D with CHD not on statins3.48 (2.43 to 4.99)2.88 (1.98 to 4.18)2.72 (1.87 to 3.95)
  T2D with CHD on statins1.61 (1.10 to 2.37)1.34 (0.90 to 1.99)1.37 (0.92 to 2.04)
  T2D without CHD not on statins1.34 (1.09 to 1.64)1.34 (1.08 to 1.64)1.27 (1.03 to 1.57)
  T2D without CHD on statins0.77 (0.46 to 1.28)0.70 (0.42 to 1.17)0.73 (0.44 to 1.23)
  • * Individuals on statin medication are identified as on statins; those not on statin medication as not on statins.

  • CVD risk factors: cholesterol, high-density-lipoprotein cholesterol, systolic blood pressure, BMI, triglycerides, hypertensive medication and current smoking.